(12) demonstrated that removal of CD4+CD25+ Tregs from the graft during transplantation accelerated the occurrence of GVHD, while addition of freshly isolated or ex vivo-expanded CD4+CD25+ Tregs could delay or even prevent GVHD after allo-HSCT. This evidence concerns the gene IL2RA and graft versus host disease.